NYSE Consumer Defensive Household & Personal Products KVUE

Kenvue Inc.

$ 18.12 0.61 %

Kenvue Inc. functions as a global leader in the consumer health sector. The company structures its operations across three primary divisions: Self Care, Skin Health and Beauty, and Essential Health. Within the Self Care unit, it offers a diverse range of products for common conditions like coughs, colds, and allergies, in addition to pain relief, digestive health, and smoking cessation aids, featuring prominent brands such as Tylenol, Nicorette, and Zyrtec. The Skin Health and Beauty segment delivers various solutions for facial, body, hair, and sun protection, recognized under popular labels including Neutrogena, Aveeno, and OGX. Moreover, the Essential Health category provides oral hygiene, infant care, feminine wellness, and wound treatment products, marketed through esteemed brands like Listerine, Johnson's, Band-Aid, and Stayfree. Established in 2022, Kenvue Inc. maintains its corporate headquarters in Skillman, New Jersey, and operates as a subsidiary of Johnson & Johnson.

CEO: Kirk L. Perry - https://www.kenvue.com

Summary 30-Y Financials Dividend Analyst Key metrics Ownership / Senat
Price objectif

$18.25 0.72 %

Recommandation

Hold

DCF

$ 30.97

Loading data...

KVUE vs S&P500

Loading data...

No data available.

Quick ratio

0.70

indicates that the company may have difficulty covering its short-term debts with its readily available assets.

P/E ratio

21.57

is considered reasonable, suggesting that the company has a valuation in line with its current profits.

EPS

0.84

is the net profit of a company divided by the number of outstanding shares, indicating the profit earned per share.

ROE

15.18 %

reflects reasonable profitability, showing good use of equity.

ROIC

9.76 %

generates a return higher than the cost of its capital, thereby creating value for its investors.

WACC

5.96

is a company's average cost of capital, weighted by the proportion of debt and equity in its financing. It represents the minimum return the company must generate to satisfy its investors.

Debt-to-Equity Ratio

0.82

indicates that the company uses more equity than debt, suggesting prudent management.

Free cash flow per share

0.95

is a measure of a company's financial flexibility that is determined by dividing free cash flow by the total number of shares outstanding.

Dividend payout ratio

0.37 %

indicates that the company is retaining a large portion of its profits to reinvest in growth

Earnings per share

Loading data...

No data available.

Financials

Piotroski score
6 indicates moderate financial health
Altman score
2.16 indicates an uncertain financial situation
Loading data...

No data available.

Cash / Debt

Cash Ratio
0.18 indicates liquidity risk, as the company may not have enough cash to meet its immediate obligations
Debt Ratio
0.32 indicates that the company uses little debt to finance its assets, suggesting good financial stability
Loading data...

No data available.

Free Cash Flow

Loading data...

No data available.

Earnings Per Share (annual)

Loading data...

No data available.

Sales

Loading data...

No data available.